SCHEMBL8540690

SCHEMBL8540690

COc1ccc(-c2ncc[nH]2)c(N)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2A P08913 1/20 0.46
ADRA2C P18825 1/20 0.46
ADRA1D P25100 1/20 0.46
ADRA1A P35348 1/20 0.46
ADRA1B P35368 1/20 0.46
TLK2 Q86UE8 2/20 0.44
ALDH1A1 P00352 5/20 0.43
MEN1 O00255 2/20 0.43
MAPT P10636 2/20 0.43
THRB P10828 2/20 0.43
KMT2A Q03164 2/20 0.43
NOS3 P29474 1/20 0.43
NOS1 P29475 1/20 0.43
NOS2 P35228 1/20 0.43
SMPD3 Q9NY59 1/20 0.43
GAA P10253 2/20 0.42
KDM4E B2RXH2 2/20 0.42
RECQL P46063 1/20 0.42
BLM P54132 1/20 0.42
MCL1 Q07820 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8542548 0.82 ADRA2A (0.57) ADRA2AADRA2CADRA1DADRA1AADRA1B
SCHEMBL11203475 0.82 NOTUM (0.54) ADRA2AADRA2CADRA1DADRA1AADRA1B
SCHEMBL6003238 0.82 PDE2A (0.55) ADRA2AADRA2CADRA1DADRA1AADRA1B
SCHEMBL6722647 0.81 AMY1A (0.55) ADRA2AADRA2CADRA1DADRA1AADRA1B
SCHEMBL8541036 0.81 SMPD3 (0.50) ADRA2AADRA2CADRA1DADRA1AADRA1B
SCHEMBL31559158 0.81 SMPD3 (0.50) ADRA2AADRA2CADRA1DADRA1AADRA1B
SCHEMBL31429681 0.81 NOTUM (0.53) ADRA2AADRA2CADRA1DADRA1AADRA1B
SCHEMBL10926149 0.79 ADRA2A (0.44) ADRA2AADRA2CADRA1DADRA1AADRA1B
SCHEMBL5248703 0.78 CSNK1A1 (0.44) ADRA2AADRA2CALDH1A1MEN1MAPT
SCHEMBL30839739 0.76 ALDH1A1 (0.61) ALDH1A1MEN1MAPTTHRBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0857171-A2 IMIDAZOLE DERIVATIVES AND THE USE THEREOF AS NITROGEN MONOXIDE SYNTHASE INHIBITORS SCHERING AKTIENGESELLSCHAFT (DE) 1998-08-12 EP disclosed
WO-1997015555-A2 IMIDAZOLE DERIVATIVES AND THE USE THEREOF AS NITROGEN MONOXIDE SYNTHASE INHIBITORS SCHERING AKTIENGESELLSCHAFT (DE) 1997-05-01 WO disclosed